INTRODUCTION
Hypertension is one of the chronic diseases affecting people especially those living in urban areas. The prevalence of hypertension in the urban areas of Tanzania is about 30 % [1] . In the HIV-infected population, the prevalence of hypertension is around 13.1 % [2] while for those patients on highly active antiretroviral therapy (HAART), it is around 21 % [3] . The use of HAART for the treatment of HIV infection is associated with the development of cardiovascular risk factors, including hypertension, hyperlipidemia, diabetes mellitus, impaired glucose tolerance, and visceral fat deposition [2, 4] .
Patients who are both HIV-positive and hypertensive are likely to be receiving multiple drug therapy as a result of medical complications associated with the disease and therefore, need intervention by a pharmacist. It has been observed that in Tanzanian public health facilities, a pharmacist is not an integral part of the health care team [5] . Consequently, patients are deprived of useful information regarding their disease, medication and quality of life issues. The various complications which result from multiple drug therapy in these patients have not been determined. In addition, the level of involvement of the pharmacist in the management of these patients in Tanzania has not been assessed. This study, therefore, focused on assessing the knowledge of hypertension among two groups of patients: hypertensive-only and hypertensive-HIV patients. The involvement of pharmacists in the counselling of these patients was also assessed. In addition, the study assessed problems which were encountered by both groups of patients in the course of using anti-hypertensive and ARV medicines alone or in combination. Pharmacists' knowledge of hypertension and cardiovascular effects due to ARV use were also assessed.
METHODS
This was a cross-sectional descriptive study conducted at hypertension and HIV clinics at four government hospitals, as well as at community pharmacies in Dar-es-Salaam, Tanzania, for a period of three months from July to September 2007.
Convenience sampling method was used. Two hundred (200) hypertensive-only patients on anti-hypertensive medicines and 200 hypertensive-HIV patients on both ARVs and anti-hypertensive medicines attending the clinics who consented to participate in the study were recruited and interviewed using questionnaires. Children, pregnant women and those not using medications were excluded from the study. A total of 100 pharmacists who consented to participate in the study were also recruited and assessed using a self-administered questionnaire in both hospital and community pharmacies. One hundred (100) dispensing encounters at the HIV clinics were observed.
Ethical clearance was obtained from the Ethical Review Committee of Muhimbili University of Health and Allied Sciences.
Data analysis
Statistical Package for Social Sciences (SPSS), version 11.5 for Windows, was used for data analysis. Frequences and percentages were determined and Chi square test was used to test for statistically significant differences
RESULTS
The demographic characteristics of the patients are shown in Table 1 . A majority of the hypertensive-only patients were in the age groups 40 -59 (46.5 %) and 60+ (47.5 %) while a majority of hypertensive-HIV patients (61 %) were middle-aged (40 -59 years). The mean age for the hypertensiveonly patients was 57.8 years (range: 27 to 102 years) and for the hypertensive-HIV Formal education 1 0.5 --patients, it was 47.1 years (range: 21 to 80 years). The male/female ratio was low in each group with females being twice as many as males. This finding was comparable in both groups. A majority in each of the patient groups had primary level education; more than a half of the subjects in both groups (71% and 58%) were unemployed. Table 2 shows the results of the knowledge of patients about their disease conditions and the source of information. Only a few of the hypertensive patients in both groups knew the names of anti-hypertensive medicines they were using. The biggest source of information on hypertension was from peer groups.
The level of knowledge of the symptoms of hypertension was significantly higher in the hypertensive-only group (60 %) than the hypertensive-HIV group (48 %) (Chi square = 5.79; p < 0.05; df = 1). Of the two groups, hypertensive-only (40.5 %) and hypertensive-HIV (29 %) patients were not aware of the consequences of uncontrolled/ untreated hypertension. Both groups reported that they were informed about the types of lifestyle modification required in their present disease conditions. The most prevalent reported lifestyle changes were low salt intake, exercise, a diet rich in fruits and vegetables, low alcohol and no smoking.
As Table 3 shows, doctors were a more frequent source of information on hypertension and ARVs than pharmacist
Information to the dispenser by the patient regarding ARV use
Only 20 % of the hypertensive-HIV patients informed the dispenser at the hypertension clinic that they were using ARVs as well. On the other hand, 36 % of the hypertensive-HIV patients informed the dispenser at the HIV clinic that they were using anti-hypertensive medicines.
Adverse drug reactions (ADRs) faced by both patient groups
The number of hypertensive-HIV patients who developed hypertension before HIV and were on anti-hypertensive medicines prior to being placed on ARVs was 104 (52 %) while those who developed hypertension after knowing their HIV status and were on ARVs prior to being placed on anti-hypertensive medicines were 96 (48 %).
Some of the hypertensive-HIV patients (22%) reported that they experienced ADRs while using anti-hypertensive medicines alone prior to being placed on ARVs. However, when these patients began to use ARVs in combination with the anti-hypertensive medicines, ADRs increased significantly (84.6 %; Chi-square = 81.833; p < 0.05; df =1). Likewise, a majority of the hypertensive-HIV patients who were on ARVs alone (82.3 %) experienced ADRs.
However, these ADRs were significantly higher (92.7 %) when they used a combination of ARVs and anti-hypertensive medicines (Chi-square = 4.766; p < 0.05; df = 1).
Fatigue (Chi square = 6.1523; p < 0.05; df = 1)) and headache (Chi square = 4.246; p < 0.05; df = 1) were more common in the hypertensive-HIV group than in the hypertensive-only group. In those patients who were using anti-hypertensive medicines prior to being placed on ARVs, fatigue and GIT disturbances were less frequently but when used in combination with ARVs, these ADRs were more frequent (fatigue, Chisquare = 19.82; p < 0.05; df = 1; and GIT disturbances, Chi-square = 57.86; p < 0.05; df = 1). However, in patients who were using ARVs prior to taking anti-hypertensive medicines, fatigue and drowsiness were less frequently reported but when used in combination with the anti-hypertensive medicines these ADRs were occurred more frequently (fatigue, Chi-square = 118.77; p < 0.05; df =1; and drowsiness, Chi-square = 45.59; p < 0.05; df = 1).
Drowsiness (Chi-square = 6.25; p < 0.05; df = 1), rash (Chi-square = 6.79; p < 0.05; df =1) and nightmares (Chi-square = 10.13; p < 0.05; df = 1) occurred significantly more in hypertensive-HIV patients who were on ARVs alone prior to being placed on antihypertensive medicines than in those who were on anti-hypertensive medicines alone prior to being placed on ARVs. 
Pharmacists' knowledge of hypertension and anti-hypertensive agents

Patient counseling
Of the 100 patients observed during the drug dispensing process, no patient was counseled on drug-drug interactions while only 2 % were asked if they were using other types of medications. 
DISCUSSION
The results obtained indicate that both groups of patients were not knowledgeable about specific factors related to hypertension such as symptoms of hypertension, consequences of uncontrolled hypertension, names of anti-hypertensive medicines they are using, and specifically their own level of blood pressure control. Lack of knowledge of hypertension can result in uncotrolled blood pressure. Studies have shown that about 50 -75 % of patients being treated for hypertension do not have adequate control of their blood pressure due to lack of knowledge of hypertension [6] [7] [8] [9] .
The median duration of hypertension for the hypertensive-only group was 6 years and for the hypertensive-HIV group was 2 years, suggesting that though these patients have had this condition for a fair long time, their knowledge of the disease was inadequate. The level of knowledge of symptoms of hypertension was significantly higher in the hypertensive-only group and this could be due to the counseling being carried out in the hypertension clinic whereby focus is on hypertension only while in the HIV clinic, counseling emphasis is on HIV only. Thus, the hypertensive-HIV patient might tend to attach more importance to HIV than hypertension.
Both groups of patients did not know the names and strength of the anti-hypertensive medicines they were using. Thus, if they experienced any adverse drug reaction or any other problems they would not be able to report which drug caused it. Moreover, they would not be able to inform the doctor or pharmacist which medicines they were using. Not knowing the consequences of uncontrolled hypertension can lead to patients not adhering to their medications thus leading to uncontrolled hypertension, leading eventually stroke, end organ damage (such as renal failure), heart failure or myocardial infarction, and blindness. A previous study has shown that patients who were aware that elevated blood pressure levels leads to reduction in life expectancy had a greater compliance level with medication use and follow up visits than patients without this awareness [10] .
In this study 22.1 % of the hypertensive-HIV and 23 % of the hypertensive-only patients developed at least one ADR when they were on anti-hypertensive medicines alone. This rate is higher than the 15.3 % previously reported in a similar study conducted in Denmark [11] but similar to the one reported by Gholami 2008 in Tehran [12] .This difference may be due to differences in the populations studied, types and number of drugs used by the patients, the definition used for ADR and susceptibility of patients to adverse reactions induced by antihypertensive medicines.
Hypertension and HIV are both chronic diseases and therefore, the use of medicines is life-long.
In this study, ADRs were significantly more frequent when a combination of ARVs and anti-hypertensive medicines were used than when either of these medicines was used. Studies have shown that antihypertensive medicines, when used together with ARVs, tend to increase the side-effects of the latter [4] .
The type of ADRs experienced when antihypertensive medicines were used alone in the hypertensive-HIV patients were almost similar to that experienced by the hypertensive-only patients.
Fatigue and headache occurred more frequently in hypertensive-HIV patients than in hypertensive-only patients. This could be due to the combined effect of the two medication types as both HIV and antihypertensive medicines cause fatigue and headache. The incidence of drowsiness was higher after hypertensive-HIV patients were placed on anti-hypertensive medicines than when they were using ARVs alone. Drowsiness is often associated with the use of anti-hypertensive medicines.
Pharmacists in Dar es Salaam were not very knowledgeable on HIV and hypertension. A majority of the pharmacists (90 %) were not aware of any HIV-related hypertensive problems. Furthermore, a majority (81 %) of them also did not have any knowledge of interactions between ARVs and antihypertensive agents. This situation is different from those of other countries where pharmacists have co-managed with doctors hypertensive patients well [13] . The patient's last stop is usually the pharmacy where the pharmacist dispenses the medicines and advises patients on their use. Thus, it is important that pharmacists have up to date knowledge so that they can assist in patient education, which can assist HIV patients to minimize problems such as drug-drug interactions, non-adherence to medications and adverse drug reactions. In this study, it both groups of patients that patient education regarding their disease conditions and medication was mostly provided by doctors and nurses.
The pharmacist was practically not involved in patient education in this regard. This is likely due to the fact that in Tanzania, hypertension clinics usually do not engage pharmacists. In this context, even if the pharmacist were to be engaged by the clinics, the pharmacist still faces certain obstacles. For instance, the current patient card of the HIV patients does not provide for the previous medication history of the patient. Thus, the pharmacist would not know whether the patient is hypertensive or not and what medications he/she is currently using. This study has revealed that patients did not know the names of the medicines they ere taking. Furthermore, in the hypertensive clinic, the patient may not want to reveal his/her HIV status and hence the pharmacist is handicapped to counsel on side effects and drug interaction. Ultimately, the patient is the loser, in that he misses out on important information regarding his disease condition likely drug interactions and ADRs.
CONCLUSION
There is a need to improve the patients' knowledge and awareness of hypertension so as to reduce the morbidity and mortality associated with hypertension. Proper coordination between HIV and hypertension clinics, as is the case for HIV and TB clinics, should help in improving patient care. At the moment, pharmacists in Tanzania are not fully integrated into the primary health care team. Pharmacists' skills should be tapped to assist patients with their long-term medicines use.
This also requires hat pharmacists' knowledge should be updated regularly.
